Nolan Advised Transnetyx in its Acquisition of Laragen

DATE: August 22, 2023

Tags: ,


Who is Our Client?

  • Transnetyx is a global leader in outsourced genetic services and a portfolio company of Thompson Street Capital Partners.
  • Founded in 2000 and headquartered in Memphis, TN, Transnetyx focuses on enabling researchers to control for biological variability in their experiments, facilitating ethical and responsible research practices.
  • Transnetyx offers a full suite of tools that advance scientific research reproducibility and replicability and provides evidence-based education and thought leadership to promote the advancement of laboratory practices.

Why Did Transnetyx Hire Nolan?

  • Transnetyx hired Nolan due to our long-standing relationship with Thompson Street Capital Partners, and expertise in the laboratory services market.

What Value Did Nolan Deliver?

  • Laragen provides sequencing, genotyping, and other laboratory services for genomics research to leading government, pharmaceutical, and academic research institutes.
  • The acquisition of Laragen furthers the Transnetyx mission to ensure that every researcher in the world has the most efficient path to discovery.
  • The addition of Sanger sequencing and next-generation sequencing (NGS) services to the Transnetyx solution suite will ultimately improve access to cutting-edge genetic services for leading research institutes around the world.
  • To view more details about this deal, please view the press release here.

Recently Closed Transactions

Engage An M&A Advisor

Contact Us

Sign Up To Receive Nolan News

FINRA Licensed Broker Dealer Affiliated

Nolan & Associates’ commonly owned affiliate, Middle Market Transactions, Inc. (MMTI), is but one of a very few FINRA licensed broker dealers serving business owners in the middle market.

Securities offered through Middle Market Transactions, Inc. Member: FINRA/SIPC

© COPYRIGHT 2024, NOLAN INVESTMENT BANKING